Hajime Asahina Selected Research

Hajime Asahina Research Topics

Disease

21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2004
17	Neoplasms (Cancer) 01/2021 - 01/2005
9	Lung Neoplasms (Lung Cancer) 02/2016 - 07/2006
7	Disease Progression 01/2021 - 03/2007
6	Adenocarcinoma of Lung 01/2019 - 07/2006
3	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2019 - 01/2005
2	Neoplasm Metastasis (Metastasis) 01/2019 - 07/2006
2	Hypertension (High Blood Pressure) 04/2017 - 06/2012
2	Adenocarcinoma 12/2006 - 01/2005
1	Pneumonia (Pneumonitis) 11/2021
1	Malignant Mesothelioma 01/2020
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020
1	Venous Thromboembolism 06/2018
1	Fever (Fevers) 04/2017
1	Headache (Headaches) 04/2017
1	Thymoma (Thymic Carcinoma) 12/2014
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2014
1	Dermatitis 09/2013
1	Thymus Neoplasms (Thymus Neoplasm) 06/2012
1	Breast Neoplasms (Breast Cancer) 06/2012
1	Sarcoma (Soft Tissue Sarcoma) 06/2012
1	Proteinuria 04/2012
1	Hypertriglyceridemia 04/2012
1	Stomatitis 04/2012
1	Neutropenia 04/2012
1	Nausea 03/2012
1	Lymphopenia (Lymphocytopenia) 03/2012
1	Lung Diseases (Lung Disease) 03/2012
1	Leukopenia 03/2012
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 12/2007
1	Meningitis 12/2007
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2007
1	Diplopia (Double Vision) 12/2007

Drug/Important Bio-Agent (IBA)

9	ErbB Receptors (EGF Receptor)IBA 11/2021 - 01/2005
8	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 09/2004
7	Gefitinib (Iressa)FDA Link 01/2010 - 01/2005
4	osimertinibIBA 11/2021 - 01/2019
4	Tyrosine Kinase InhibitorsIBA 01/2021 - 12/2006
3	Pemetrexed (MTA)FDA Link 01/2021 - 12/2018
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2018 - 09/2013
3	amrubicinIBA 12/2014 - 04/2012
2	PlatinumIBA 01/2021 - 12/2014
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2018 - 11/2017
2	AntibodiesIBA 03/2016 - 02/2016
2	AnthracyclinesIBA 12/2014 - 05/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2012 - 09/2004
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2006 - 01/2005
1	AfatinibIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2021
1	NivolumabIBA 01/2020
1	Inosine Triphosphate (ITP)IBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 12/2019
1	Chemokine ReceptorsIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	dabrafenibIBA 01/2019
1	Bevacizumab (Avastin)FDA Link 12/2018
1	edoxabanIBA 06/2018
1	RamucirumabIBA 04/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2017
1	necitumumabIBA 11/2016
1	CytokinesIBA 03/2016
1	LigandsIBA 03/2016
1	B7-H1 AntigenIBA 02/2016
1	Dasatinib (BMS 354825)FDA Link 10/2015
1	(+)-JQ1 compoundIBA 10/2015
1	Discoidin Domain Receptor 2IBA 10/2015
1	CH 4987655IBA 06/2015
1	RO5126766IBA 09/2013
1	Creatine Kinase (Creatine Phosphokinase)IBA 09/2013
1	Mechanistic Target of Rapamycin Complex 1IBA 06/2013
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 06/2013
1	Insulin-Like PeptidesIBA 08/2012
1	figitumumabIBA 08/2012
1	linifanibIBA 06/2012
1	Pharmaceutical PreparationsIBA 04/2012
1	amrubicinolIBA 04/2012
1	ridaforolimusIBA 04/2012
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2012
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2012
1	SteroidsIBA 03/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2012
1	olaparibIBA 03/2012
1	CreatinineIBA 03/2012
1	locked nucleic acidIBA 01/2012
1	Peptide Nucleic AcidsIBA 01/2012
1	NucleotidesIBA 12/2007
1	Amylases FDA Link 07/2006
1	Biological ProductsIBA 07/2006

Therapy/Procedure

13	Therapeutics 11/2021 - 03/2012
6	Drug Therapy (Chemotherapy) 01/2021 - 01/2010
1	Radiotherapy 01/2021
1	Renal Dialysis (Hemodialysis) 12/2007